13.4 C
Cape Town
Sunday, April 19, 2026

The South African Health Products Regulatory Authority has announced it will facilitate a controlled, compassionate access programme for the use of Ivermectin. The anti-parasitic drug has gained popularity over recent weeks for its supposed benefits to treat COVID-19. SAHPRA once again stressed there was not enough scientific evidence to enable a regulator to make a decision on the drug’s use.

Published on

Latest articles

WATCH: South Africa now makes critical molecule for lab-grown meat

 A South African biotechnology breakthrough could help make lab-grown meat more affordable and accessible. Lab-grown meat is considered the future of food because it offers...

Tributes pour in after sudden passing of Johnny Davids

  The Afrikaans lifestyle channel VIA (DStv channel 147) has paid tribute to television personality Johnny Davids, who passed away suddenly on Thursday morning at...

SASSA Moves to End ‘Unlawful’ Queue Selling Practice

 The South African Social Security Agency (SASSA) has intensified its warning against the illegal sale of queue positions at its offices, vowing a crackdown...
error: Content is protected !!